For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the introduction of Vyndamax and the formulated version represents a genuine advancement . These innovative therapies stabilize the transthyretin protein, preventing its harmful build-up and lessening the burden of the disease . Patients are now … Read More